FDA sends letter to Novo Nordisk over potential GLP-1 side effects
The U.S. Food and Drug Administration sent a warning letter this month to Novo Nordisk, the maker of…
FDA sends letter to Novo Nordisk over potential GLP-1 side effects
The U.S. Food and Drug Administration sent a warning letter this month to Novo Nordisk, the maker of…
Australia issues mental health alert on weight-loss drugs as WHO sets new guidelines – The Week
Australia’s Therapeutic Goods Administration (TGA) issued updated safety warnings for GLP-1 receptor agonists, a fast-growing class of diabetes…